alexa Patent Execution Strategies
ISSN: 2375-4516

Intellectual Property Rights: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Patent Execution Strategies

Md. Faiyazuddin*

Nanopharmaceutical & Drug Delivery Research Lab (NDDRL), Faculty of Pharmacy, Integral University, Lucknow 226 060, Uttar Pradesh

*Corresponding Author:
Md. Faiyazuddin
Assistant Professor & Principle Investigator
Nanopharmaceutical & Drug Delivery Research Lab (NDDRL)
Faculty of Pharmacy, Integral University
Kursi Road, Lucknow 226060
Uttar Pradesh, INDIA
Tel: +0091-0522-2890730(O)
Fax: +0091-0522-2890809
Tel: +0091-9044712679
E-mail: [email protected]; [email protected]

Received Date: December 26, 2013; Accepted Date: December 26, 2013; Published Date: December 31, 2013

Citation: Faiyazuddin Md. (2013) Patent Execution Strategies. Intel Prop Rights 2:e102. doi: 10.4172/2375-4516.1000e102

Copyright: © 2013 Faiyazuddin Md. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Patents are considered to be enticements for innovation and thereby expected to benefit humanity by making available to the society. Pharmaceutical patents cover products that take a very long time to develop and the patent life is actually closer to 11 or 12 years since federal law requires a company to test its product for safety and efficacy and secure regulatory approval before marketing. Developing countries experience shows that such incentives focus on the market demand rather than the need of the society. This is more obvious in the health related innovation. Therefore, a strong IP protections safeguard should be held against counterfeit, illegitimate and fake pharmaceutical products.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords